Septodont's Biodentine "bioactive" dentine substitute now has more than 1000 scientific publications on Pubmed supporting the major benefits it brings in restorative, endodontic and paediatric procedures.
This increase in the number of publications is indicative of a strong scientific community endorsing Biodentine and researchers' interest on all the benefits of this product. Biodentine is a tricalcium silicate-based material designed to be a permanent dentin substitute. It is bioactive and biocompatible and was developed using the purist form of calcium silicate cement. The Septodont research team persevered in combining their efforts in creating the patented Active Biosilicate Technology (ABS) with the completed formulation surpassing Portland Cement.
Tuesday, 26 November, 2024